Skip to main content

DexCom, Inc.

Company History

DexCom History: Founding, Growth & Key Milestones

Founded 1999 in San Diego, California

When was DexCom founded?

DexCom was founded in 1999 in San Diego, California by Scott Glenn and Chuck Sherman, making it 27 years old.

Founded
1999
Founding place
San Diego, California
Founders
Scott Glenn and Chuck Sherman
Headquarters today
San Diego, California
Milestones documented
16 (1999–2026)
Current CEO
Kevin Sayer
Acquisitions
2
YearEvent
1999Founded in San Diego
2006IPO & First FDA Approval
2008Dexcom SEVEN Launch
2012Dexcom G4 Platinum
2015Dexcom G5 Mobile
2018G6 Launch & TypeZero Acquisition
2019$1.4B Revenue Milestone
2020Tandem Control-IQ Integration
2021$2.4B Revenue Cross
2022Dexcom G7 Clearance
2023$3.62B Revenue Record
2024Stelo OTC Launch
2025Global User Base Expansion
2026Next-Gen Multi-Analyte Biosensors
2026Manufacturing Scale-Up
2026Market Cap Milestone
Where was DexCom founded?
DexCom was founded in San Diego, California in 1999. corporate.bestbuy.com
Who founded DexCom?
DexCom was founded by Scott Glenn and Chuck Sherman.
When did DexCom start?
DexCom was founded in 1999.
How old is DexCom?
DexCom is 27 years old as of 2026.

Founding Story

In 1966, Richard M. Schulze and James Wheeler opened Sound of Music in Saint Paul, Minnesota. In 1981, a devastating tornado ripped the roof off their largest location. Schulze held a massive 'Tornado Sale' in the parking lot, slashing prices to the bare minimum. The overwhelming consumer response inspired the 1983 rebranding to Best Buy.

Founders

Scott Glenn

Pioneering medical device entrepreneur who founded Dexcom in 1999 with a vision to eliminate fingerstick testing through continuous glucose monitoring.

Chuck Sherman

Key engineering pioneer who contributed to early electrochemical sensor design and foundational intellectual property.

Key Milestones

1999

Founded in San Diego

Dexcom founded in San Diego, California by Scott Glenn to revolutionize diabetes care.

Source: investors.dexcom.com
2006

IPO & First FDA Approval

Completes initial public offering on NASDAQ under DXCM and receives FDA approval for first CGM.

Source: investors.dexcom.com
2008

Dexcom SEVEN Launch

Introduction of the Dexcom SEVEN system, marking a significant leap in sensor longevity.

Source: investors.dexcom.com
2012

Dexcom G4 Platinum

Launch of the G4 Platinum, revolutionizing CGM accuracy and pediatric approval.

Source: investors.dexcom.com
2015

Dexcom G5 Mobile

FDA approves G5 Mobile, the first CGM with mobile app connectivity without a receiver.

Source: investors.dexcom.com
2018

G6 Launch & TypeZero Acquisition

Launch of Dexcom G6 featuring zero fingersticks and acquisition of TypeZero Technologies.

Source: investors.dexcom.com
2019

$1.4B Revenue Milestone

Annual revenues surpass $1.4 billion as global patient adoption accelerates rapidly.

Source: investors.dexcom.com
2020

Tandem Control-IQ Integration

Integration with Tandem Control-IQ automated insulin delivery closed-loop system.

Source: investors.dexcom.com
2021

$2.4B Revenue Cross

Revenue crosses $2.4 billion with international expansion spanning over 90 countries.

Source: investors.dexcom.com
2022

Dexcom G7 Clearance

FDA clearance of the Dexcom G7 featuring a 60% smaller footprint and 30-minute warm-up.

Source: investors.dexcom.com
2023

$3.62B Revenue Record

Annual revenues reach $3.62 billion with net income scaling to $541 million.

Source: investors.dexcom.com
2024

Stelo OTC Launch

Launch of Stelo, the first FDA-cleared over-the-counter biosensor for type 2 non-insulin diabetes.

Source: investors.dexcom.com
2025

Global User Base Expansion

Global installed user base surpasses 2.5 million active diabetes patients worldwide.

Source: investors.dexcom.com
2026

Next-Gen Multi-Analyte Biosensors

Advancement of multi-analyte biosensors and expanded automated pump partnerships.

Source: investors.dexcom.com
2026

Manufacturing Scale-Up

Expansion of high-volume automated manufacturing facilities in Arizona and Malaysia.

Source: investors.dexcom.com
2026

Market Cap Milestone

Market capitalization surpasses $32 billion amid robust institutional adoption.

Source: investors.dexcom.com

Major Acquisitions

2018

2017

Keep researching DexCom

DexCom Company History FAQ

When was Dexcom founded and who started it?

Dexcom was established in 1999 in San Diego, CA. The founders launched the enterprise with a clear mission to innovate within Medical Devices and CGM, pioneering new operational models and customer-centric financial solutions that transformed traditional marketplace practices.

What were the most important milestones in Dexcom's history?

Key historical milestones for Dexcom include its initial foundation in 1999, the rollout of proprietary operational and digital platforms, major institutional capital expansions, strategic corporate acquisitions, and its evolution into a recognized market titan generating .62B in annual revenue.

How did Dexcom survive historic economic downturns?

Dexcom navigated major economic crises and market volatility by preserving conservative balance sheet reserves, diversifying its core revenue streams across multiple customer segments, and leveraging low-cost operational infrastructure to maintain positive operating margins when competitors struggled.

Where is Dexcom headquartered today?

Dexcom maintains its global corporate headquarters in San Diego, CA, directing enterprise strategy, regulatory compliance, technology engineering, and international customer operations from this central location.

Related Strategic History

Compare founding milestones and corporate evolution

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.